Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:03 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 1,562 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: method comparison Clear all

Conditions: Lumbar Spine Fusion, Pain, Back Pain
Interventions: Epidural Catheter - Dilaudid, Dilaudid; Other · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Critical Limb Ischemia
Interventions: MOTIV Sirolimus-Eluting Bioresorbable Scaffold, Percutaneous Transluminal Angioplasty (PTA) Device; Device
Lead sponsor: REVA Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 292 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 25
States / cities: El Centro, California • Fremont, California • St. Helena, California + 22 more

Conditions: Vascular Accident, Brain, CVA (Cerebrovascular Accident), Gait, Hemiplegic, Spastic Lower Extremity Weakness
Interventions: Transcranial direct current stimulation (tDCS); Device
Lead sponsor: Texas Woman's University; Other
Eligibility: 21 Years to 90 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hypoglycemia
Interventions: Continuous Glucose Monitoring, activity monitor, Mixed meal tolerance test, Glucagon Sensitivity Testing, Hypoglycemic Hyperinsulinemic Clamp, analysis of fecal microbiome; Diagnostic Test
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alzheimer Disease and Related Dementias (ADRD)
Interventions: Passive Digital Marker for screening for ADRD; Other
Lead sponsor: Indiana University; Other
Eligibility: 65 Years and older
Enrollment: 1,281 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boca Raton, Florida

Conditions: Tuberculosis Infection
Interventions: Aplisol@ PPD material, Reference Standard; Biological
Lead sponsor: JHP Pharmaceuticals LLC; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Tyler, Texas

Conditions: Multiple Myeloma (MM)
Interventions: PET-enabled dual-energy CT imaging, X-ray dual-energy CT imaging; Diagnostic Test
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Skin Aging
Interventions: SkinPen Precision System; Device
Lead sponsor: Crown Laboratories, Inc.; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Allergy
Interventions: Skin Testing; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 187 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Pulmonary Hypertension, Pulmonary Vascular Disease, Left Heart Disease
Interventions: Transthoracic Echocardiography (TTE), Lung ultrasound; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Total Hip Arthroplasty
Interventions: PENG Block, Lidocaine; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Birmingham, Alabama

Conditions: Diabetes Mellitus, Type 2
Interventions: Insulin detemir; Drug
Lead sponsor: Diabetes Care Center; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Salinas, California

Conditions: Atrial Fibrillation, Atrial Flutter, Heart Block, Pulmonary Embolism and Thrombosis, Mitral Valve Repair, Sinus Node Dysfunction, Bradycardia, Brady-tachy Syndrome
Interventions: Perclose ProGlide Suture-Mediated Closure System (SMC) - LARGE-BORE PROCEDURES, Figure 8 Suture - LARGE-BORE PROCEDURES; Device · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Stroke
Interventions: Thigh Cuff; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 50 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: 3D mammograpgy system; Device
Lead sponsor: Hologic, Inc.; Industry
Eligibility: 40 Years and older · Female only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Multiple Sclerosis, Healthy
Interventions: Blood draw; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Metastatic Cancer
Interventions: Fluorodeoxyglucose F18, Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI), Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI), General Electric (GE) SIGNA PET/MR; Drug · Procedure · Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome
Interventions: ATIR101, Cyclophosphamide, T-cell depleted HSCT from a related, haploidentical donor, T-cell replete HSCT from a related, haploidentical donor; Biological · Drug · Procedure
Lead sponsor: Kiadis Pharma; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 12
States / cities: Duarte, California • La Jolla, California • Los Angeles, California + 8 more

Conditions: Sleep Disordered Breathing (SDB), Sleep Apnea
Interventions: SSAM, Polysomnography, EnsoSleep; Device · Diagnostic Test
Lead sponsor: Pathway Medtech, LLC.; Industry
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 3
States / cities: Burlingame, California • Irvine, California • La Jolla, California

Conditions: Cardiac Output
Interventions: Not listed
Lead sponsor: Transonic Systems Inc.; Industry
Eligibility: Up to 16 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Down Syndrome, Chromosome Abnormalities
Interventions: Ultrasound, Serum screen; Procedure
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 16 Years to 45 Years · Female only
Enrollment: 38,000 participants
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 10
States / cities: Denver, Colorado • Boston, Massachusetts • Royal Oak, Michigan + 6 more

Conditions: Liver Cancer
Interventions: Blood draw; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes
Interventions: ONYX NEXT BGMS; Device
Lead sponsor: Ascensia Diabetes Care; Industry
Eligibility: 18 Years and older
Enrollment: 376 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 2
States / cities: Escondido, California • Walnut Creek, California

Conditions: Initial Caries, Arrested Dental Caries, Cavitated Caries, Dental Caries, Dental Caries in Children
Interventions: Curodont Repair Fluoride Plus, Silver Diamine Fluoride, Glass Ionomer Sealant, Fluoride varnish, Fluoride toothpaste; Drug · Device
Lead sponsor: CareQuest Institute for Oral Health; Other
Eligibility: 4 Years and older
Enrollment: 744 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: Dothan, Alabama • Westborough, Massachusetts • Bend, Oregon + 1 more

Search by objective public record fields.

Epidural Analgesia Versus IV Analgesia in Lumbar Spine Fusions

MOTIV BTK Randomized Controlled Trial

Effect of Brain Stimulation on Stepping Performance in Stroke Survivors and Healthy Adults

Mechanisms of Post-Bariatric Hypoglycemia

Digital Detection of Dementia (D Cubed) Studies: D3

Equivalence Study of Specificity of PPD

PET-Enabled Dual-Energy CT in Multiple Myeloma

A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Skinpen on Male and Female Subjects' Dorsal Hands as a Treatment of Hand Aging

Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation

Pulmonary Hypertension in Left Heart Disease

Trial Comparing Impact of PENG Block on Quality of Recovery Compared to No-block for Primary Total Hip Arthroplasty

A Comparison of Two Initial Dosing Formulas

Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial

Non-invasive Measurement of Cerebral Dynamic Autoregulation

A Comparison of the 15 and 30 Acquisition Angle Breast Tomosynthesis Mammography for Breast Abnormalities

COVID-19 Vaccine Response in Treated MS Patients

Comparison of Whole Body DWI to FDG PET

Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer

Detection of Sleep Stages and Arousals Using Neural Network Classifiers

Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Pediatric Patients

Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters

Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)

Evaluation of a Ascensia ONYX NEXT Investigational Blood Glucose Monitoring System

Early Caries Lesion Management Observational Study